Enclosed herewith News Paper Publication of Financial Results for the Quarter and Nine Months ended on December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Daikaffil Chemicals India Ltd has informed BSE that its Q3 FY26 and nine-month ended December 31, 2025 unaudited financial results were published in The Free Press Journal (English, Mumbai) and Navshakti (Marathi, Mumbai) on February 12, 2026. For the quarter ended December 31, 2025, the company reported standalone total income of Rs. 148.11 lakhs and a net loss of Rs. 33.72 lakhs (EPS of Rs. -0.56). For the nine-month period, total income stood at Rs. 1,141.63 lakhs with a net loss of Rs. 124.97 lakhs, against a total income of Rs. 375.55 lakhs and net loss of Rs. 132.62 lakhs in the corresponding nine months of the previous year. The board had approved these results on February 10, 2026. The filing is a routine regulatory disclosure under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a procedural compliance filing; the actual results were already disclosed on February 10, 2026. The company continues to report losses at both quarterly and nine-month levels, though nine-month revenue has roughly tripled year-on-year, indicating some operational recovery but no profitability yet.